Edition:
United States

Proteon Therapeutics Inc (PRTO.OQ)

PRTO.OQ on NASDAQ Stock Exchange Global Market

2.05USD
21 Sep 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$2.05
Open
$2.05
Day's High
$2.05
Day's Low
$1.85
Volume
38,278
Avg. Vol
7,597
52-wk High
$2.90
52-wk Low
$1.55

Chart for

About

Proteon Therapeutics, Inc. is a late-stage biopharmaceutical company, which focuses on the development of pharmaceuticals to address the needs of patients with renal and vascular disease. The Company is involved in research and development activities. The Company's product candidate, product candidate, vonapanitase, formerly... (more)

Overall

Beta: 1.45
Market Cap(Mil.): $36.34
Shares Outstanding(Mil.): 17.73
Dividend: --
Yield (%): --

Financials

  PRTO.OQ Industry Sector
P/E (TTM): -- 108.45 32.71
EPS (TTM): -2.02 -- --
ROI: -104.57 1.54 12.72
ROE: -211.75 0.30 14.84

BRIEF-Proteon Therapeutics Announces Qtrly Loss Per Share $0.34

* PROTEON THERAPEUTICS ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS

May 09 2018

BRIEF-Proteon Therapeutics And Lonza Extend Manufacturing Agreement For Commercial Supply

* PROTEON THERAPEUTICS AND LONZA EXTEND MANUFACTURING AGREEMENT FOR COMMERCIAL SUPPLY

May 08 2018

Earnings vs. Estimates